Intervention Review

Infliximab for the treatment of rheumatoid arthritis

  1. Barbara BTB Blumenauer1,*,
  2. Maria Judd2,
  3. George A Wells3,
  4. Amanda Burls4,
  5. Ann Cranney5,
  6. Marc C Hochberg6,
  7. Peter Tugwell7,
  8. Maria Angeles Lopez-Olivo8

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 22 JUL 2002

Assessed as up-to-date: 26 MAY 2002

DOI: 10.1002/14651858.CD003785


How to Cite

Blumenauer BBTB, Judd M, Wells GA, Burls A, Cranney A, Hochberg MC, Tugwell P, Lopez-Olivo MA. Infliximab for the treatment of rheumatoid arthritis. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003785. DOI: 10.1002/14651858.CD003785.

Author Information

  1. 1

    Kamloops, British Columbia, Canada

  2. 2

    Canadian Health Services Research Foundation/Fondation canadienne de la recherche sur les services de santé, Research Use/Agente principale de programme, Utilisation de la Recherche, Ottawa, Ontario, Canada

  3. 3

    University of Ottawa Heart Institute, Cardiovascular Research Reference Centre, Ottawa, Ontario, Canada

  4. 4

    University of Oxford, Department of Primary Health Care, Oxford, Birmingham, UK

  5. 5

    Ottawa Hospital, Division of Rheumatology, Ottawa, Ontario, Canada

  6. 6

    University of Maryland, School of Medicine, Baltimore, MD, USA

  7. 7

    Ottawa Hospital, Centre for Global Health, Institute of Population Health, Department of Medicine, Ottawa, Ontario, Canada

  8. 8

    The University of Texas, M.D. Anderson Cancer Center, General Internal Medicine, Ambulatory Treatment and Emergency Care, Houston, Texas, USA

*Barbara BTB Blumenauer, 206-300 Columbia St, Kamloops, British Columbia, V2C 6L1, Canada. bblumenauer1@bellnet.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 22 JUL 2002

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Aimee Kendall Roundtree, Michael A. Kallen, Maria A. Lopez-Olivo, Barbara Kimmel, Becky Skidmore, Zulma Ortiz, Vanessa Cox, Maria E. Suarez-Almazor, Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: A systematic review, Journal of Clinical Epidemiology, 2009, 62, 2, 128

    CrossRef

  2. 2
    Tessa Sanderson, Michael Calnan, Marianne Morris, Pam Richards, Sarah Hewlett, The impact of patient-perceived restricted access to anti-TNF therapy for rheumatoid arthritis: a qualitative study, Musculoskeletal Care, 2009, 7, 3
  3. 3
    Bruno Fautrel, Thao Pham, Gaël Mouterde, Xavier Le Loët, Philippe Goupille, Francis Guillemin, Philippe Ravaud, Alain Cantagrel, Maxime Dougados, Xavier Puéchal, Jean Sibilia, Martin Soubrier, Xavier Mariette, Bernard Combe, Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde, Revue du Rhumatisme, 2007, 74, 12, 1301

    CrossRef

  4. 4
    Bruno Fautrel, Arnaud Constantin, Jacques Morel, Olivier Vittecoq, Alain Cantagrel, Bernard Combe, Maxime Dougados, Xavier Le Loët, Xavier Mariette, Thao Pham, Xavier Puéchal, Jean Sibilia, Martin Soubrier, Philippe Ravaud, Recommendations of the French Society for Rheumatology. TNFα antagonist therapy in rheumatoid arthritis, Joint Bone Spine, 2006, 73, 4, 433

    CrossRef

  5. 5
    J.-H. Yen, Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?, Biomedicine & Pharmacotherapy, 2006, 60, 10, 688

    CrossRef

  6. 6
    R. Ruano Camps, M.V. Ordóñez Martí-Aguilar, C. Gallego Fernández, V. Coret Cagigal, I.M. Muñoz Castillo, Infliximab en artritis reumatoide. Utilización en un hospital de tercer nivel, Farmacia Hospitalaria, 2005, 29, 2, 113

    CrossRef

  7. 7
    Lara Maxwell, Jasvinder A Singh, Abatacept for rheumatoid arthritis, The Cochrane Library,
  8. 8
    Lara Maxwell, Jasvinder A Singh, Abatacept for rheumatoid arthritis, The Cochrane Library,
  9. 9
    Jasvinder A Singh, George A Wells, Robin Christensen, Elizabeth Tanjong Ghogomu, Lara Maxwell, Luciane C Lopes, John K MacDonald, Graziella Filippini, Damian Francis, Gordon H Guyatt, Michael PT Lunn, Jochen Schmitt, Nicole Skoetz, Peter Tugwell, Rachelle Buchbinder, Adverse effects of biologics: a network meta-analysis and Cochrane overview, The Cochrane Library,
  10. 10
    Jasvinder A Singh, George A Wells, Robin Christensen, Elizabeth Tanjong Ghogomu, Lara Maxwell, John K MacDonald, Graziella Filippini, Nicole Skoetz, Damian K Francis, Luciane C Lopes, Gordon H Guyatt, Jochen Schmitt, Loredana La Mantia, Tobias Weberschock, Juliana F Roos, Hendrik Siebert, Sarah Hershan, Chris Cameron, Michael PT Lunn, Peter Tugwell, Rachelle Buchbinder, Adverse effects of biologics: a network meta-analysis and Cochrane overview, The Cochrane Library,
  11. 11
    Marty Mertens, Jasvinder A Singh, Anakinra for rheumatoid arthritis, The Cochrane Library,
  12. 12
    Celia Almeida, Sarah Hewlett, John R Kirwan, Fiona Cramp, Trudie Chalder, Ernest HS Choy, Biologic interventions for fatigue in rheumatoid arthritis, The Cochrane Library,
  13. 13
    Jasvinder A Singh, Robin Christensen, George A Wells, Maria E Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu, Peter Tugwell, Biologics for rheumatoid arthritis: an overview of Cochrane reviews, The Cochrane Library,
  14. 14
    Vicente Ruiz Garcia, Paresh Jobanputra, Amanda Burls, Juan B Cabello, José G Gálvez Muñoz, Encarnación SC Saiz Cuenca, Anne Fry-Smith, Certolizumab pegol (CDP870) for rheumatoid arthritis in adults, The Cochrane Library,
  15. 15
    Vicente Ruiz Garcia, Paresh Jobanputra, Amanda Burls, Juan B Cabello, Paloma Vela Casasempere, Sylvia Bort-Marti, Francis JB Kynaston-Pearson, Certolizumab pegol (CDP870) for rheumatoid arthritis in adults, The Cochrane Library,
  16. 16
    Noortje van Herwaarden, Alfons Den Broeder, Wilco Jacobs, Johannes WJ Bijlsma, Ronald F Van Vollenhoven, Bart(holomeus) JF Van den Bemt, Down titration and discontinuation strategies of tumor necrosis factor blocking agents for rheumatoid arthritis in patients with low disease activity, The Cochrane Library,
  17. 17
    Noortje van Herwaarden, Alfons A den Broeder, Wilco Jacobs, Aatke van der Maas, Johannes WJ Bijlsma, Ronald F van Vollenhoven, Bart(holomeus) JF van den Bemt, Down-titration and discontinuation strategies of tumor necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity, The Cochrane Library,
  18. 18
    Arturo J Martí-Carvajal, Luis H Agreda-Pérez, Ivan Solà, Daniel Simancas-Racines, Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis, The Cochrane Library,
  19. 19
    Jasvinder A Singh, Shahrzad Noorbaloochi, Gurkirpal Singh, Golimumab for rheumatoid arthritis, The Cochrane Library,
  20. 20
    Jean-Noel Vergnes, Paul Monsarrat, Alessandra Blaizot, Cathy Nabet, Alain Cantagrel, Michel Sixou, Susan Furness, Interventions for periodontal disease in people with rheumatoid arthritis, The Cochrane Library,
  21. 21
    Celia Almeida, Trudie Chalder, Fiona Cramp, Ernest HS Choy, John R Kirwan, Sarah Hewlett, Jon Pollock, Robin Christensen, Non-biologic pharmaceutical interventions for fatigue in rheumatoid arthritis, The Cochrane Library,
  22. 22
    Vidhu Anand, Sushil K Garg, Maria Angeles Lopez-Olivo, Jasvinder A Singh, Ofatumumab for rheumatoid arthritis, The Cochrane Library,
  23. 23
    Femke HM Prince, Anna K Dorai Raj, Marieke H Otten, Peter PM Cheung, Kathleen E Tymms, Lisette WA van Suijlekom-Smit, Johannes C van der Wouden, TNF-alpha inhibitors for juvenile idiopathic arthritis, The Cochrane Library,
  24. 24
    Dominik Golicki, Tomasz Macioch, Maciej Niewada, Michal Jakubczyk, Malgorzata Tlustochowicz, Witold Owczarek, Witold Tlustochowicz, TNF-alpha inhibitors for psoriatic arthritis, The Cochrane Library,
  25. 25
    Jasvinder A Singh, Saba Beg, Maria Angeles Lopez-Olivo, Tocilizumab for rheumatoid arthritis, The Cochrane Library,
  26. 26
    Jasvinder A Singh, Saba Beg, Maria Angeles Lopez-Olivo, Tocilizumab for rheumatoid arthritis, The Cochrane Library,